BioGend Therapeutics Co Ltd

ROCO:6733 (Taiwan)   Ordinary Shares
NT$ 36.85 (-1.47%) May 23
At Loss
P/B:
4.88
Market Cap:
NT$ 4.58B ($ 141.90M)
Enterprise V:
NT$ 3.91B ($ 121.02M)
Volume:
100.00K
Avg Vol (2M):
173.55K
Volume:
100.00K
At Loss
Avg Vol (2M):
173.55K

BioGend Therapeutics Co Ltd Valuation Measures